
SCOTTSDALE, Ariz. — A recent Mayo Clinic study on yips, a condition that has baffled golfers and scientists for decades, will be a featured presentation ...
ROCHESTER, Minn. — Mayo Clinic and partners from the University of Pennsylvania School of Veterinary Medicine, the University of Minnesota College of Veterinary Medicine and College of Pharmacy, the Perelman School of Medicine at the University of Pennsylvania, and NeuroVista Corporation have been awarded a $7.5 million grant (U01) from the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health (NIH). The research involves studying new ways to predict and control epileptic seizures in dogs and people. VIDEO ALERT: Journalists: video of a canine seizure is available at the Mayo Clinic News Blog. Epilepsy affects approximately 1 percent of the human population, with an estimated 50 million people worldwide currently suffering from the disorder. The hallmark of epilepsy is the seizure — a sudden and often violent event that strikes patients without warning. The goal of the research is to use information gleaned from real-time electroencephalograms (EEG) to consistently detect impending seizures, and develop methods of preventing these seizures through use of fast-acting drug therapies. The grant awards $1.5 million a year for up to five years. The principal investigators of the studies are Greg Worrell, M.D., Ph.D., Mayo Clinic; Ned Patterson, D.V.M., Ph.D., University of Minnesota College of Veterinary Medicine; Jim Cloyd, Pharm.D., University of Minnesota College of Pharmacy; Charles Vite, D.V.M., Ph.D., University of Pennsylvania School of Veterinary Medicine; Brian Litt, M.D., Perelman School of Medicine at the University of Pennsylvania; and Kent Leyde, chief technology officer of NeuroVista Corporation of Seattle, Washington. NeuroVista, a Seattle based company developing novel technologies for the management and treatment of epilepsy, has developed an implantable device system that continuously collects and analyzes EEG data to detect impending seizures. The system uses an external patient-carried device with a very simple interface—three colored lights—to indicate the risk of an impending seizure to the patient. The system is currently undergoing study in clinical trials in human patients being conducted in Australia. The NIH-funded research will involve applying the NeuroVista technology to dogs with naturally occurring epilepsy, and extending the technology by using it to guide the administration of fast-acting drugs to prevent seizures. It is hoped that this work will translate to a similar solution for human patients.
JACKSONVILLE, Fla. — Researchers have identified a gene that causes adult-onset primary cervical dystonia, an often-painful condition in which patients' necks twist involuntarily. The discovery by a team from the Jacksonville, Fla., campus of Mayo Clinic and the University of Tennessee Health Sciences Center sheds light on a movement disorder that physicians previously could seldom explain. Their research appears in the Annals of Neurology. In 1990, a man with a crooked neck came to see Ryan Uitti, M.D., a neurologist then at Mayo Clinic in Rochester, Minn. Dr. Uitti knew about adult-onset primary cervical dystonia, which results in involuntary twisting of the neck to the left or right, backward or forward. Most people who have it suffer from muscle pain and abnormalities in head position. Some don't think it is all that unusual and may not seek medical help, Dr. Uitti says. "They think they slept wrong at some point, or, because the twisting might straighten out with another maneuver, such as walking backwards, they might actually be accused of being a little crazy," Dr. Uitti says. Dr. Uitti had been taught that there is usually no explanation for the disorder, when it shows up in adulthood. But working with a team of neurologists who have found the genetic causes of other rare conditions, Dr. Uitti began to investigate.
ROCHESTER, Minn. — Mitochondria — subunits inside cells that produce energy — have long been thought to play a role in Alzheimer's disease. Now Mayo Clinic researchers using genetic mouse models have discovered that mitochondria in the brain are dysfunctional early in the disease. The findings appear in the journal PLoS ONE. The group looked at mitochondria in three mouse models, each using a different gene shown to cause familial, or early-onset, Alzheimer's disease. The specific mitochondria changes corresponded with the mutation type and included altered mitochondrial movement, structure, and energy dynamics. The changes happened in the brain even before the mice showed any symptoms such as memory loss. The group also found that the mitochondrial changes contributed to the later loss of mitochondrial function and the onset and progression of Alzheimer's disease. "One of the most significant findings of this study is our discovery of the impact of mitochondrial dysfunction in Alzheimer's disease," says Eugenia Trushina, Ph.D., Mayo Clinic pharmacologist and senior investigator on the study. "We are asking: Can we connect the degree of mitochondrial dysfunction with the progression of symptoms in Alzheimer's disease?" Enlisting the expertise of Mayo researcher Petras Dzeja, Ph.D., the team applied a relatively new method called metabolomics, which measures the chemical fingerprints of metabolic pathways in the cell — sugars, lipids, nucleotides, amino acids and fatty acids, for example. It assesses what is happening in the body at a given time and at a fine level of detail, giving scientists insight into the cellular processes that underlie a disease. In this case, the metabolomic profiles showed changes in metabolites related to mitochondrial function and energy metabolism, further confirming that altered mitochondrial energetics is at the root of the disease process.
ROCHESTER, Minn. — In a reversal of two decades of medical reports, a Mayo Clinic study finds the frequency of nerve damage called diabetic polyneuropathy is similar in prediabetic patients and healthy people. Physicians should seek explanations other than prediabetes for patients who have painful small fiber polyneuropathy, the researchers say. The study was published in the March issue of Diabetes Care. Diabetic polyneuropathies, or DPN, are commonly associated with diabetes and chemical derangements related to high blood sugar. The neuropathies can injure nerve fibers throughout the body, but usually affect the feet and legs. The nerve damage can create sensory, motor and bodily function problems. DPN can be painful and life-threatening. "It is highly unlikely that impaired glucose or associated metabolic derangements cause polyneuropathy, at least not to the high frequency previously reported," says lead author Peter J. Dyck, M.D., a Mayo Clinic neurologist. The five-year study, "Impaired Glycemia and Diabetic Polyneuropathy: The OC IG Survey," tested nearly 550 people representative of a community of older patients of Northern European extraction. Of these, 150 individuals were healthy subjects, 174 had prediabetes indicators, and 208 had newly developed type 2 diabetes. The study concluded that typical or atypical (a painful small-fiber variety) DPN was not more prevalent in prediabetics than in healthy people.
SCOTTSDALE, Ariz. — A new study from Mayo Clinic supports the idea that "what's good for your heart is good for your brain." The study, released today, suggests that eating too much may double the risk for memory loss in people age 70 and older. This research will be presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28. VIDEO ALERT: Click here for a video of Dr. Geda explaining the study. "We observed a dose-response pattern which simply means; the higher the amount of calories consumed each day, the higher the risk of mild cognitive impairment," said study author Yonas E. Geda, M.D., MSc, a neurologist and psychiatrist with Mayo Clinic in Arizona. He noted that 2,143 calories per day may double the risk of memory loss. While the relationship between cardiovascular problems and overeating are well known, the study further documents the similarities of cardiovascular risks and neurological risks such as mild cognitive impairment, Dr. Geda says. MCI is the stage between normal memory loss that comes with aging and early Alzheimer's disease. The study involved 1,233 people in Olmsted County, Minn., ages 70 to 89 and free of dementia. Of those, 163 had MCI. Participants reported the amount of calories they ate or drank in a food questionnaire and were divided into three equal groups based on their daily caloric consumption. One-third consumed 600 to 1,526 calories per day, one-third 1,526 to 2,143 calories and one-third 2,143 to 6,000 calories per day. The odds of having MCI more than doubled for people in the highest calorie-consuming group compared with people in the lowest calorie-consuming group. The results were the same after adjusting for history of stroke, diabetes, amount of education and other factors that can affect risk of memory loss. There was no significant difference in risk for the middle group.
On Saturday, February 25th our guest was Mayo Clinic physician Dr. Ronald Petersen discussing Alzheimer's disease. Medical Edge Weekend 2-25-12 The Mayo Clinic Alzheimer's disease blog can be found ...
PHOENIX — It's been said that marriage is good for your health — especially if you're a man. Research at Mayo Clinic in Arizona shows that's true when it comes to seeking care for stroke symptoms. A Mayo Clinic study, presented at the American Stroke Conference in New Orleans in early February, says that men experiencing a stroke call for emergency help quicker than women, especially if they are married. "Marriage has long been shown to offer health benefits and often more for men," said Joyce Lee-Iannotti, M.D., a neurology Fellow at Mayo Clinic in Arizona and author of the study. "The reasons are unclear, but it's been postulated that it can be societal roles, where women take on the roles of caregivers and advise their spouses to seek care, often putting their own health behind that of their children and husband." VIDEO: Dr. Lee-Iannotti explains the study. The study was a retrospective review of 209 patients with acute stroke symptoms brought by emergency medical services to Mayo Clinic in Phoenix over 15 months ending in November 2011. Researchers collected participants' age, gender, marital status, time of symptom awareness and time of emergency medical services dispatch. They compared the time from symptoms awareness to EMS dispatch between married and single participants and between men and women. Married men called within 28 minutes of symptoms compared to married women, who called an average of 67 minutes after their first stroke symptoms. Single men activated EMS earlier than single women, but the difference was not significant.
JACKSONVILLE, Fla. — A research team led by investigators at Mayo Clinic in Florida has found that a small device worn on a patient's brow can be useful in monitoring stroke patients in the hospital. The device measures blood oxygen, similar to a pulse oximeter, which is clipped onto a finger. VIDEO ALERT: Additional audio and video resources, including comments by Dr. Freeman about the new device, are available online. Their study, published in the Feb. 1 issue of Neurosurgical Focus, suggests this tool, known as frontal near-infrared spectroscopy (NIRS), could offer hospital physicians a safe and cost-effective way to monitor patients who are being treated for a stroke, in real time. "About one-third of stroke patients in the hospital suffer another stroke, and we have few options for constantly monitoring patients for such recurrences," says the study's senior investigator, neurocritical care specialist William Freeman, M.D., an associate professor of neurology at Mayo Clinic. "This was a small pilot study initiated at Mayo Clinic's campus in Florida, but we plan to study this device more extensively and hope that this bedside tool offers significant benefit to patients by helping physicians detect strokes earlier and manage recovery better," he says.
A research team led by investigators at Mayo Clinic in Jacksonville, FL has found that a small device worn on a patient’s brow can be useful in monitoring stroke patients in the hospital. Researchers say the device might offer a reliable way to monitor hospitalized patients for recurrent strokes in real time. The device measures blood oxygen, similar to a pulse oximeter, which is clipped onto a finger. Their study, published in the Feb. 1 issue of Neurosurgical Focus, suggests this tool, known as frontal near-infrared spectroscopy (NIRS), could offer hospital physicians a safe and cost-effective way to monitor patients who are being treated for a stroke, in real time.
ROCHESTER, Minn. — Researchers involved in the Mayo Clinic Study of Aging reported today that more than 6 percent of Americans age 70 to 89 develop mild cognitive impairment (MCI) every year. Also, the condition appears to affect men and those who only have a high school education more than women and those who have completed some higher education. People with MCI are at the stage between suffering the normal forgetfulness associated with aging and developing dementia, such as that caused by Alzheimer's disease. VIDEO ALERT: Additional audio and video resources, including excerpts from an interview with Dr. Roberts describing the research, are available on the Mayo Clinic News Blog. The study, "The Incidence of MCI Differs by Subtype and is Higher in Men," which was published in the Jan. 25, 2012, issue of Neurology, the medical journal of the American Academy of Neurology, reports that 296 of the 1,450 study participants developed MCI, an incidence rate of 6.4 percent per year overall. Among men, the incidence rate was 7.2 percent, compared with 5.7 percent per year for women. "While incidence rates for MCI have been reported previously, ours is one of the few studies designed specifically to measure the incidence of MCI and its subtypes using published criteria," says lead author Rosebud O. Roberts, M.B., Ch.B., of the Mayo Clinic Division of Epidemiology. "The statistically significant difference between incidence rates among men and women represents an important finding for those evaluating patients for MCI." The study also looked in more detail at patients with MCI, dividing them according to whether they developed amnestic MCI (aMCI) — in which the condition affects the memory domain — or non-amnestic MCI (naMCI).
https://www.youtube.com/watch?v=NeZZIzLRxGs It wasn’t supposed to happen. A freak accident during a college football game leaves a player paralyzed. Doctors gave him a 3-percent chance ...
An online patient support community